Pharmaxis announces sustained benefit in cystic fibrosis following long term bronchitol treatment

17th May 10

Release Date: 17/05/2010 12:00am

Pharmaxis today announced significant headline results for the final stage of its international Phase III trial of Bronchitol (inhaled mannitol) in people with cystic fibrosis.


Read full media release - pdf

Categories: News and Media